Amping up estrogen receptors in breast cancer
Open Access
- 16 August 2007
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research
- Vol. 9 (4) , 305
- https://doi.org/10.1186/bcr1748
Abstract
This article highlights a recent study by Holst et al. in Nature Genetics that finds estrogen receptor-alpha (ER-α) amplification in early benign lesions and more advanced invasive carcinomas of the breast, and discusses the potential implications to our present understanding of the role of ER-α in breast tumorigenesis.Keywords
This publication has 24 references indexed in Scilit:
- The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-α (ERα) and Represses ERα Messenger RNA and Protein Expression in Breast Cancer Cell LinesMolecular Endocrinology, 2007
- Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cellsOncogene, 2007
- Novel patterns of genome rearrangement and their association with survival in breast cancerGenome Research, 2006
- Caveolin-1 Mutations in Human Breast CancerThe American Journal of Pathology, 2006
- A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer PatientsCancer Research, 2005
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Abnormal regulation of the oestrogen receptor in benign breast lesionsJournal of Clinical Pathology, 2000
- Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodiesJournal of Steroid Biochemistry, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896